Reprogramming in vivo produces teratomas and iPS cells with totipotency features. - Wikidata - awgldk - TriplyDB

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

http://www.wikidata.org/entity/Q34038104

about

Cell injury, retrodifferentiation and the cancer treatment paradox Research on induced pluripotent stem cells and the application in ocular tissues Induced pluripotent stem cell technology for dissecting the cancer epigenome Induced pluripotent stem cell (iPSCs) and their application in immunotherapy Differentiated type II pneumocytes can be reprogrammed by ectopic Sox2 expression The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.Vascular diseases await translation of blood vessels engineered from stem cells In Situ Pluripotency Factor Expression Promotes Functional Recovery From Cerebral Ischemia Oncogenic senescence: a multi-functional perspective.Reprogramming the cardiac field Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation Convergence of stem cell behaviors and genetic regulation between animals and plants: insights from the Arabidopsis thaliana stomatal lineage.Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly.Renal stem cell reprogramming: Prospects in regenerative medicine.Regenerative Cell Therapy for Corneal Endothelium.Stem cell transplantation in neurological diseases: improving effectiveness in animal models Modulating the stem cell niche for tissue regeneration.Cellular reprogramming for understanding and treating human disease.In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.Simple insoluble cues specify stem cell differentiation Reprogramming the genome to totipotency in mouse embryos Endogenous gradients of resting potential instructively pattern embryonic neural tissue via Notch signaling and regulation of proliferation.Reprogramming of human cancer cells to pluripotency for models of cancer progression Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins.Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.SOX2 reprograms resident astrocytes into neural progenitors in the adult brain.MicroRNA-Mediated In Vitro and In Vivo Direct Conversion of Astrocytes to Neuroblasts.Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium.Intrinsic factors and the embryonic environment influence the formation of extragonadal teratomas during gestation In vivo reprogrammed pluripotent stem cells from teratomas share analogous properties with their in vitro counterparts.CtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem Cells Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases.Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor.Physiological, pathological, and engineered cell identity reprogramming in the central nervous system.Embryo-like features of induced pluripotent stem cells defy legal and ethical boundaries.Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis.Totipotency: what it is and what it is not Gene delivery to Nile tilapia cells for transgenesis and the role of PI3K-c2α in angiogenesis Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury

P2860

Q26783201-41C09A5A-EA26-45F8-9C91-DB041C623932 Q26796711-F5C7FAAF-4B03-4396-B2E6-8CB92067D93B Q26801711-E36A1206-F62B-48F4-BB5E-3ED33CA58D01 Q26996540-AFDC641E-B4E0-44E7-A186-3B23B5031BB8 Q27347937-2A004609-06C3-4036-A2D7-2CBA41A39188 Q27691322-6D0FE7CB-A161-4F93-B0B4-93EA7F72CD14 Q28083072-39F1FDBB-0B22-44BF-98F5-D5EC36614E2E Q30828997-5CA20CC4-E920-4A19-97D8-1DA953911305 Q33689160-5A4D874C-75AA-400D-9DA5-EF628BEC6D05 Q33716314-C60565E0-F9D7-4C3E-937A-1E8B870091B0 Q33891224-88953559-CBD1-4764-A2D9-B1015080BDB9 Q33942088-74D3044D-95E5-44EF-90E1-986D4BC54A86 Q34044606-55AC2E80-9861-4326-8FE1-D71599091327 Q34232871-6A7B1564-9A38-4EF3-9539-E3EF98B1F6CF Q34334949-DFAF2FC7-07CD-4FCA-A84C-E303F178CE65 Q34391064-0A497AA6-ABB9-422D-BF02-D0DA9A3BAF73 Q34432431-3DB7AC83-9C5B-4668-9250-01AD734A7266 Q34496408-0BC3A2E9-EB1A-4B42-B312-2E2A4DCF44FB Q34547502-AAC5820C-7B3B-4230-85DA-4F4931775D09 Q34793527-73A679DC-C1E0-4415-88DC-AEDA7427BE7C Q35034392-1B40C83E-57C6-44DC-9BC3-14C9A0A03884 Q35164097-5A50B11D-7DEB-4434-A99D-8E78642974C8 Q35204997-F1A3A9E1-1F5B-4D94-9AC0-97512096A4C3 Q35550151-0479BC1E-2F2B-41A1-A0DE-32128C2906B0 Q35590331-EBE08B08-4162-4853-8456-AA1ED63614C5 Q35623883-37FA6C1A-404C-4550-B499-120861E17587 Q35648513-E38F8E97-C3F0-4C38-AD49-7333C5BB786A Q35748408-25CFF265-B7C4-4B3C-A24F-F1EA3A7FE964 Q35802373-4757D01D-7925-4049-A9B2-000C2AC17874 Q36002719-8B9F70EF-400C-4E27-823F-C571E60F5308 Q36243930-C3AB5A47-C16C-4101-9ED2-55F007BB2025 Q36554387-7C6E2E62-5243-4FC1-8C30-D3DDDBF21E92 Q36751660-F261422A-6690-4A74-8B82-1A241C985225 Q36958987-E5D5AA68-ACA7-49A4-BA5B-81B9F8E10EEC Q37014278-1726E8DD-FB6B-484B-AE99-E2C806EF0C48 Q37487349-9F79D7C6-C113-4200-97D5-BC2AAB202C77 Q37644735-DB7ECAF4-AA90-43FC-84E5-D8865B91E8A5 Q37710687-99EBA7B0-BE99-4C60-8D38-D6F6BF2190EE Q37710895-4C54CB14-A5C6-4C5F-96B0-E889D3CFA9FB Q37712423-9DD3F80E-015F-4787-93AE-0A6084D47E39

P2860

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

http://www.wikidata.org/entity/Q34038104

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@ast

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@en

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@nl

type

label

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@ast

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@en

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@nl

prefLabel

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@ast

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@en

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

@nl

P1433

Q34038104-64E8205C-23D4-4E9E-B5F0-71F85D8F1544

P1476

Q34038104-447C70A3-1408-465B-8233-B5E119C2EBB1

P2093

Q34038104-0FB1CDAE-FAF1-4C80-BA74-54B382B4F6B4

Q34038104-10C2B21F-74ED-44D5-B8DB-E9015B763E14

Q34038104-577DE758-1168-4CC7-B26C-0C80CB4D5B5D

Q34038104-CDB0C525-C854-4A20-8893-B5F0D57A4AB2

Q34038104-E38A6173-B426-4FCF-8DD9-3EFEE0CB8A78

Q34038104-F3261D43-EA9F-4F5C-AD78-27B7D2242675

Q34038104-F8C78FBC-0994-46A0-BAE5-B3BE8D62D42E

P2888

Q34038104-8530E519-562A-44A1-8D6A-40F9D7965201

P304

Q34038104-736E8EBF-FD83-4C85-B029-2DA13562A6CE

P31

Q34038104-CE40E4B9-0103-4C45-ADCA-84365A952298

P356

Q34038104-ACE1FDED-66FF-4C09-8695-09D0C85A4FA5

P407

Q34038104-34FFFF07-59D3-4464-AE7C-C80515366888

P433

Q34038104-DDDB7417-ECA4-4E30-BA3C-10CC7E404097

P478

Q34038104-03763167-1480-45BE-91E2-DC068BF844D9

P50

Q34038104-0938CF53-DAD5-4D0D-B772-72469057647B

Q34038104-A91E2359-89C1-4716-B65A-5CAEB5A6981A

Q34038104-AC2665DC-A3C0-4B52-8229-B3AB9BF917BE

Q34038104-B58A1C43-D2AB-496C-B844-8823E3437AB1

Q34038104-BE7A5479-4265-44E8-8161-28A6FA6C2D30

Q34038104-C1335E9C-AFD4-4D5C-8206-34E0973F0AFD

P577

Q34038104-E360AD8A-6B94-4DC1-BD0F-CBABC5139CA7

P5875

Q34038104-58ED8C45-E7C7-41F3-9016-6770DE3A779E

P6179

Q34038104-9F02B6A8-F281-4AD8-A58C-2814CCDE9112

P698

Q34038104-DDBEC933-5BEC-425A-AA52-EC820197396D

P356

P1433

P1476

Reprogramming in vivo produces teratomas and iPS cells with totipotency features

@en

P2093

Dolores Martínez

http://www.w3.org/2001/XMLSchema#string

Inmaculada Ors

http://www.w3.org/2001/XMLSchema#string

Lluc Mosteiro

http://www.w3.org/2001/XMLSchema#string

Marta Cañamero

http://www.w3.org/2001/XMLSchema#string

Orlando Domínguez

http://www.w3.org/2001/XMLSchema#string

Osvaldo Graña

http://www.w3.org/2001/XMLSchema#string

Sagrario Ortega

http://www.w3.org/2001/XMLSchema#string

P2888

P304

340-345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE12586

http://www.w3.org/2001/XMLSchema#string

P407

P433

7471

http://www.w3.org/2001/XMLSchema#string

P478

502

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Pantoja

Miguel Manzanares

P577

2013-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256500474

http://www.w3.org/2001/XMLSchema#string

P6179

1031878804

http://www.w3.org/2001/XMLSchema#string

P698

24025773

http://www.w3.org/2001/XMLSchema#string